Growth momentum Carebox has secured a significant growth equity investment from H.I.G. Growth (Nov 2024), signaling strong investor confidence and potential for scaled sales initiatives to expand enterprise partnerships with pharma sponsors, CROs, and large hospital networks.

Clinical trial reach The platform connects patients, families, and physicians to treatment options in clinical trials, addressing enrollment challenges and diversity mandates, presenting a compelling value proposition for sponsors seeking faster, more diverse enrollment and site optimization.

Strategic collaborations Recent partnerships with Lupus Foundation of America and TOUCH Black Breast Cancer Alliance indicate a track record of co-creating patient-centric trial finder experiences, suggesting opportunity to upsell co-branded trial finder solutions to additional disease communities.

Expansion-ready tech A tech stack that includes HubSpot, iCIMS, WordPress, Shopify, and analytics tools supports marketing, applicant tracking, and digital commerce capabilities, enabling scalable lead generation, partner onboarding, and self-serve trial finder experiences for sponsors.

Market positioning With revenue in the multi-million range and a focus on patient-centric enrollment, Carebox sits between niche trial matching platforms and broad EHR-driven patient recruitment, offering a specialized path for pharma and CROs to improve enrollment timelines and budget adherence.